BFS vs Preformed Aseptic Filling: Choosing a Skincare Route

The comparison is about container timing. In one route the polymer unit is formed, filled and sealed in the same cycle. In the other, a bottle, vial or tube already exists and is supplied to a filling line with its own closure.

If you need the filling-method definition, start with what aseptic packaging means in skincare manufacturing. If the live question is polymer BFS versus a glass ampoule, use BFS vs traditional ampoules.

When to compare the two routes

Open the comparison when at least one of the following is true:

• The container is not yet specified, and both an in-line formed unit and a supplied vial or bottle are still plausible.
• A component supplier has offered a vial, tube or closure, and you need to know whether that system can be prepared, filled and closed as a preformed brief.
• Dose, opening and secondary pack could still be designed into a BFS mould, and you have not checked that path against buying the pack in.

Park the comparison when a named bottle, vial or closure is already required, and the remaining work is whether that system fits a preformed filling route.

Formed in process versus a supplied vial or closure

BFS starts with polymer and a mould. The container is created on the machine that fills and closes it. Preformed filling starts with parts that already exist: a vial or bottle, a stopper, a cap, a nozzle. Those parts have their own supply, preparation and closing steps before the formula is in a sealed unit.

Equipment literature describes the same split in process terms: forming, filling and sealing in one cycle, versus a line fed with containers made elsewhere. See Rommelag on aseptic packaging and aseptic filling machines. That description is background for the timing difference. It is not a statement about this site's equipment, output or accreditation.

For a skincare brief, that timing usually shows up in three places:

• Component handling. Preformed work has to account for empty-container supply, preparation and a separate closure. BFS makes the pack in the cycle.
• Opening design. A BFS opening is usually designed with the mould. A preformed brief inherits the opening the vial or closure already has, unless that component is still being selected.
• Format lock. A specified bottle or vial makes preformed filling a candidate to review. BFS is a candidate when the unit, dose and opening can still be designed together.

Neither sequence, by itself, proves the incoming formula is suitable for the process. Suitability is a project review of formula, container and market together.

Fit checks that belong on both routes

Run the same questions against each route still in play. The BFS manufacturing page explains the in-line sequence; it does not replace this list.

• Formula at fill. Viscosity, sensitivity to process conditions, and whether the composition has been reviewed against the container materials on that route.
• Dose and opening. The amount in the unit and how the user is expected to get it out. A moulded twist-off and a supplied cap are different answers.
• Secondary pack. Strip, tray, carton or a presentation that already assumes a certain footprint.
• Supply of the pack. For preformed: can the specified vial and closure be sourced, prepared and kept identified as the manufacturing version? For BFS: is the mould and polymer version named, or still a sketch?

Route decision checkpoints

A working sequence for brand and packaging teams. It is a conversation order, not a validation calendar.

1. Lock the container question. Is a specified bottle, vial or closure already required, or can the unit still be formed in process?
2. Map preparation and closing. For a preformed pack: how the empty container and closure enter the filling step. For BFS: the moulded unit and its opening.
3. Name a sample version. One geometry, one opening, one fill target, on the route still under discussion.
4. List what the sample must answer. Fill, close, dispense, handle and pack-out, as questions, not as a public pass mark.
5. Separate remaining project review. Formula suitability, inspection scope, documentation and commercial terms stay in the project file.

What this comparison does not settle

Aseptic filling describes a controlled filling method. It does not mean the incoming formula is sterilised by being filled. Where a higher control objective is required, that is agreed for the product, container and market. Capacity, order quantity, cycle time and certificates stay in the project file. Glass ampoule filling remains a dedicated preformed route; use the glass comparison when barrier or break-open presentation is the actual question.

Hypothetical: specified vial versus an open format

The following scenario is hypothetical. It shows how the checkpoints would be used. It is not a client history.

A clinic-channel serum arrives with a 1.5 ml polymer vial and a twist cap already chosen by the brand's packaging team. The pack exists, so the first checkpoint is container timing. The review asks whether that vial and cap can be prepared, filled and closed as a preformed brief, and what sample version would demonstrate fill, closure and dispense. BFS is not the starting route while the specified vial remains a requirement.

A second brand has the same serum concept and no pack. Dose, opening and carton are still open. The team puts BFS on the list because the unit can be formed in process. They put a preformed vial on the list only if a component they intend to buy is named. They leave with one sample version per remaining route and a list of what each sample must answer.

Buyer decision checklist

If you cannot answer the first two items, you are still choosing whether the container already exists, not yet choosing a filling route.

1. Does a specified bottle, vial, tube or closure already have to travel with this SKU?
2. If not, can dose, opening and pack-out still be designed with a formed-in-process unit?
3. Have formula, opening and secondary pack been reviewed against each route still in play?
4. Is there a named sample version on each remaining route, or only a slide comparing machine stories?
5. What must that sample answer before the other route is dropped?
6. Which items, formula suitability, inspection, documentation, commercial terms, remain in project review regardless of the route name?

When the container question is written down, read the two technology pages against the same brief. Start with preformed aseptic filling if a supplied pack is on the table; keep the BFS page open if the unit can still be formed in process.